Sacral
Nerve Stimulation (SNS) is an electrical stimulation therapy for the treatment
of bladder control and bowel control symptoms. A programmable stimulator is
implanted subcutaneously to deliver electrical stimulation through a lead to
the sacral nerve. This is a clinically proven treatment for overactive bladder
(OAB) patients which significantly improve quality of life as compared to
patients on therapeutics.
OAB
is one of the most common condition affecting millions of people worldwide.
Sudden urge to urinate is the most common symptom of OAB. This urge is
difficult to stop and hence leads to involuntary leaking of urine (known as
incontinence). OAB affects 85 million adults in Europe and the U.S. and 40
million people are suffering from fecal incontinence. Over the past two
decades, this therapy has been widely adopted in the U.S. and Europe for the
treatment of OAB, primarily due to availability of favorable reimbursement.
Browse
Full Report @ https://www.crystalmarketresearch.com/report/sacral-nerve-stimulation-market
Rise
in prevalence of OAB symptoms coupled with rapidly aging population, increased
research and development (R&D) efforts by SNS manufacturers, and
technological advancements in SNS systems are set to boost the adoption of SNS
systems. However, side-effects associated with SNS systems will hinder the
market growth. But, the development of O-arm guided navigation systems, and
antibacterial and bioabsorbable technology are the current industry trends,
which will bring in huge growth opportunities for the manufacturers.
Moreover,
innovation is set to derive the demand for sacral neuromodulation systems
globally. Therefore, major players emphasize on new product development in
order to gain competitive advantage. For instance, in January 2017, Axonics
Modulation Technologies, Inc. obtained approval from Health Canada for its
rechargeable Sacral Neuromodulation (r-SNM) System, which is designed for the
treatment of overactive bladder, urinary retention, and fecal incontinence.
Likewise, in February 2017, Nuvectra Corporation filed regulatory submissions
for CE mark and FDA approvals for its Virtis Sacral Nerve Stimulation System.
This system can be used to treat overactive bladder and chronic urinary
retention. Thus, development of such innovative SNS systems to meet the unmet
medical needs will further contribute to the market growth.
Request
for an in-depth table of contents for this report @ https://www.crystalmarketresearch.com/request-toc/upcoming/HC06144
Additionally,
increased research and development (R&D) efforts is one of the key drivers
for the growth of this market. In line with this strategy, major companies are
raising finances for conducting studies on SNS systems. For instance, in May
2017, Axonics Modulation Technologies, Inc. obtained $14.5 million for a
pivotal study of its neuromodulation system in overactive bladder patients.
Further, it aims to raise $30 million to kick off its U.S. pivotal study, which
is expected to be conducted in Europe and the U.S. Prior to this, the company
has received $38.5 million for its SNS system.
Some
of the major players operating in this market are Axonics Modulation
Technologies, Inc, Medtronic plc, and Nuvectra Corporation. Medtronic has
monopoly in the global SNS Market. The company has strong product portfolio of
both external and implantable SNS devices. It offered innovative treatments to
around 225,000 patients globally through its InterStim system.
Make an inquiry @ https://www.crystalmarketresearch.com/send-an-enquiry/HC06144
About Crystal Market Research
Crystal
Market Research is a U.S. based market research and business intelligence
company. Crystal offers one stop solution for market research, business
intelligence, and consulting services to help clients make more informed
decisions. It provides both syndicated as well as customized research studies
for its customers spread across the globe. The company offers market
intelligence reports across a broad range of industries including healthcare,
chemicals & materials, technology, automotive, and energy.
Contact:
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Website:
http://www.crystalmarketresearch.com
No comments:
Post a Comment